Yimucao Shenghua Mixture veterinary grade API enters downstream formulation as a multicomponent botanical extract rather than a single synthetic molecule; blend behaviour, moisture sensitivity, and microbial load are therefore determined by extraction solvent, dry matter content, residual solvent profile, and particle-size distribution of the spray-dried or dehumidified extract. Formulators commonly receive the material at a dry matter concentration of 92%–98% when spray-dried or 50%–70% when supplied as a soft extract paste, and each presentation forces a distinct premix, granulation, or dissolution sequence. The mixture is used in post-partum veterinary regimens and gynecological supportive care, but the downstream dosage form must be designed around analytical markers, total ash, acid-insoluble ash, heavy metals per USP <232>/<233>, and total aerobic microbial count declared in the certificate of analysis. The following sections separate the applications by finished dosage form and process risk; deep-dive treatment is applied only where process thresholds or incompatibilities govern product quality.

Injectable Aseptic Processing and Endotoxin Risk in Post-Partum Ruminant Formulations

Injectable solutions of botanical mixtures are not produced by simple dissolution; the extract must first be reconstituted in Water for Injection, chilled to 4°C–8°C, and clarified through a disc-stack centrifuge operating at 8,000–11,500 rpm because coarse herb residues and calcium oxalate-like crystals otherwise blind downstream membrane cassettes. The clarified liquor is passed through 0.45 μm polypropylene prefilters followed by a 0.22 μm polyethersulfone sterilizing-grade filter, but filtration alone does not remove endotoxin released from Gram-negative bacteria introduced with field-harvested aerial parts. Depyrogenation is performed by ultrafiltration through a 10 kDa hollow-fiber module or by activated-carbon treatment, which reduces pyrogen load but may also subtract polyphenolic components. The solution pH is maintained at 5.2–5.8 with citrate buffer because precipitation of flavone aglycones increases above pH 6.5; the same precipitate can form during terminal sterilization if local pH excursion occurs in a non-buffered liquid phase. Aseptic processing under ISO 14644-1:2015 cleanroom classification ISO 7, in conjunction with terminal steam sterilization at 121°C for 15 minutes when justified by stability data, is the standard microbial control strategy. The sterilized solution must meet sterility per USP <71>, bacterial endotoxins per USP <85>, particulate matter per USP <788>, and pH per USP <791>. Published data for heat-stress degradation of leonurine-type alkaloids in this specific mixture under saturated steam are limited; terminal steam sterilization therefore requires a prior thermal stability protocol at 121°C for the exact fill volume.

Production-scale failure modes in herbal injection lines occur most often at the point of mixing concentrated extract into Water for Injection. If the extract is dumped into a 500 L jacketed stainless-steel vessel without a high-shear disperser, the outer layer hydrates into a gel-like film that protects an undissolved core; this yields high particulate counts after 72 hours cold storage. A bottom-entry rotor-stator mixer running at 3,000 rpm for 20–30 minutes under nitrogen purging reduces oxygen ingress and shortens wetting time. Nitrogen sparging at 0.5–1.0 L/min during compounding limits oxidative darkening; sodium metabisulfite is generally avoided because it can react with alkaloid constituents. Silicone rubber tubing and non-polar elastomers are preferred over natural rubber closures to reduce extract sorption. The filled containers are inspected for visible particles against black and white backgrounds under 2,000–3,000 lux; any batch showing glass delamination or thread-like protein-polysaccharide aggregates is failed under USP <790> visible particulate inspection criteria.

In drinking-water application, the concentrated oral liquid is metered into farm water lines at dilutions of 1:500 to 1:5,000, and stability in the dilution water is the limiting technical criterion rather than extraction marker recovery. Groundwater with bicarbonate hardness of 180–300 mg/L CaCO₃ causes suspended herb particles to flocculate because calcium bridges carboxyl and phenolic groups present on the extracted plant matrix. A stabilizer system of 0.05%–0.15% xanthan gum, or 0.5%–1.0% propylene glycol alginate, is incorporated into the concentrated oral solution after hydration at 80°C for 30 minutes to avoid fisheye formation. The concentrated solution is adjusted to pH 4.0–4.5 with citric acid before preservative addition; sodium benzoate at 0.1%–0.2% is largely ineffective above pH 5.5 because the ionized benzoate ion does not penetrate microbial membranes. Preservative efficacy is challenged by USP <51>, and the diluted solution at 1:1,000 in alkaline groundwater may fail the same challenge when measured pH exceeds 6.0 after 72 hours. For this reason many oral liquids are formulated with a citrate–benzoate buffer reserve, and the label states a maximum dilution ratio above which pH-mediated preservative failure becomes likely.

Light and oxidant stress in the drinking-water distribution system alter the colour of the diluted product from amber to dark brown without necessarily indicating loss of efficacy. Nevertheless, the oral solution is compounded in light-resistant HDPE or amber glass with light transmission of less than 10% at 450 nm, and the bulk liquid is blanketed with nitrogen to keep dissolved oxygen below 1.5 mg/L. Free chlorine at 0.5–1.0 ppm is common in municipal water and can oxidize leonurine and phenolic markers; sodium thiosulfate is added only after chlorine measurement exceeds 1.5 ppm, because excess thiosulfate can itself act as a reducing agent and destabilize complex polysaccharide–polyphenol colloids. Microbial enumeration of the non-sterile oral liquid follows Ph. Eur. 2.6.12 and 2.6.13, with acceptance criteria drawn from Ph. Eur. 5.1.4 for oral liquids of natural origin.

What Restricts Blend Uniformity in Two-Tonne Herbal Premix Lines?

A medicated premix is normally prepared at 0.2%–1.0% w/w of dry extract in a feed carrier, and the process window is controlled less by chemistry than by particle-size and density mismatch. The spray-dried extract of this mixture typically has an aerated bulk density of 0.45–0.60 g/cm³, a tapped density of 0.55–0.75 g/cm³, and a particle-size distribution where 90% of particles are below 250 μm; carriers such as ground rice hulls or corn cob fractions at 0.25–0.40 g/cm³ segregate during bucket elevator transfer. A twin-shaft paddle mixer with a working volume of 2,000 kg achieves an active-marker coefficient of variation below 5.0% only when the herbal API is first geometrically pre-blended with an equal mass of carrier and passed through a 500 μm in-line sieve, then added to the main mixer at 25 rpm for 10–12 minutes. Over-mixing beyond 15 minutes does not improve homogeneity; it raises static charge on dried herb particles and may convert the mixture into a sticky wall-adherent layer on high-density polyethylene surfaces, particularly at relative humidity above 60%.

Moisture governs premix shelf life and mycotoxin risk more than active-marker distribution. Carrier moisture should be held below 8%, and finished premix water activity should remain below 0.55 to suppress fungal growth and caking. When the formulation is intended for use in poultry or swine feeds that contain choline chloride, the mineral carrier calcium carbonate must be avoided or reduced to below 5% of premix mass because choline chloride is hygroscopic and liberates moisture, inducing local pH above 8.0 at the carrier–API interface; this alkaline microenvironment accelerates oxidation of polyphenolic fractions. Table 1 gives typical carrier options and selection constraints, but batch-specific flow and density data must be verified before scale-up.

The cleanout and cross-contamination boundary for a premix containing herbal extract is defined by swab recovery of the marker compound, not by visual inspection. If the line also processes synthetic antimicrobials, a dedicated hammermill or sifter and a washdown sequence with 70% ethanol followed by hot water at 80°C are required because alkaloid-containing dust adheres to cyclone walls and static-prone flexible connectors. Tests of the finished premix include quantitative analysis of the marker compound, blend uniformity according to the sampling scheme specified in 21 CFR Part 225 for medicated feed facilities, and mycotoxin screening according to AOAC Official Method 2005.08 for aflatoxin B₁ in botanical feed matrices.

Tablet manufacture from the dry extract is most stable as a wet-granulated intermediate because direct compression fails at punch speeds above 30 rpm on rotary presses when granulation feed contains more than 5% moisture or when ambient relative humidity exceeds 55%. The extract is combined with 5%–10% polyvinylpyrrolidone K30 dissolved in ethanol–water (70:30) or with 8%–12% pregelatinised starch paste, then granulated through a 16-mesh screen and dried in a fluid-bed dryer with inlet air not exceeding 60°C. Exceeding 68°C inlet air causes surface case hardening on the granules, so tablet disintegration becomes variable and hardness may fall below 50 N if cores are compressed immediately after drying. The target granule moisture is 3.0%–5.0%; below 2.0% the granules become brittle and generate fines above 30% in the hopper, which causes weight variation at the compression stage. A lubricant level of 0.75% magnesium stearate is standard. Raising the lubricant above 1.5% coats the herbal granules with a hydrophobic film and can push disintegration beyond 45 minutes in USP <701> water at 37°C; this effect is amplified when the formulation contains high levels of extract-derived polysaccharides.

Disintegrant selection changes with granule moisture. Crospovidone at 2.0%–4.0% is preferred when granule moisture is near 4.5% because its capillary wicking remains effective in the presence of humectant plant polysaccharides, while sodium starch glycolate at 4% may hydrate prematurely and leave pinholes in the tablet surface after compression. Compressed tablets require hardness of 60–100 N and friability below 1.0% per USP <1216>. A hydroxypropyl methylcellulose/polyethylene glycol film coat at 3% weight gain is applied to reduce water-vapour ingress when blister films are not high-barrier Aclar or aluminium laminates. Published data for dissolution testing of this specific herbal tablet under USP <711> are limited; a disintegration release-control strategy is therefore used in many veterinary registrations when marker dissolution has not been fully validated.

Capsule Powder Moisture Ingress and Gelatin Crosslinking at RH 60%

Hard-capsule filling of the dried extract is possible when the fill is granulated and equilibrated to a water activity below 0.50. Spray-dried extract powders with water activity above 0.55 transfer moisture to the capsule shell within 24–48 hours at 25°C and 60% relative humidity; gelatin capsule shells can then crosslink through aldehyde–amine reactions with oxidised plant constituents or simply soften and jam the closing station on high-speed machines. Hydroxypropyl methylcellulose capsules eliminate the aldehyde–gelatin reaction but increase electrostatic adhesion on tamping-pin machines, so the formulation includes 1.0% colloidal silicon dioxide and 20% microcrystalline cellulose to suppress static. The granulated fill is passed through an 800 μm sieve and filled at 25°C and 35%–45% relative humidity; fill weight variation is held below ±3% for 500 mg capsule fill weights. Near-infrared moisture sensors on the feed shoe reject feeding when powder water activity exceeds 0.55.

If the API is supplied as a paste, capsule filling is not recommended without prior conversion to a dry granulate. A paste at 50%–70% dry matter is first mixed with microcrystalline cellulose and maltodextrin in a sigma-blade mixer, then dried in a vacuum shelf dryer at 45°C and 80–100 mbar to avoid thermal degradation; after drying, the cake is milled through a 1.0 mm screen and passed through a 40-mesh sieve before blending. The resulting powder may show poor flow, necessitating 0.5% fumed silica and 2% crospovidone. Capsule testing generally relies on marker content and weight variation; if a marker assay is available, dissolution can follow USP <711>, but published data for this specific herbal mixture remain limited.

When Oral Granules Are Fluid-Bed Sprayed With Aqueous Binder Above the Extract's Softening Point

Oral granules are manufactured by top-spray fluid-bed granulation using a binder solution of 5% hydroxypropyl methylcellulose E5 or 10% acacia. The critical variable is product temperature; the dry extract softens above 50°C and sticks to the bag filter when a 600 L granulator is operated with inlet air above 65°C. Inlet air at 50–60°C and product temperature below 45°C allow spray rates of 60–120 g/min for a 500 kg charge. Spray rates above 150 g/min overwet the powder, causing agglomerates that exceed 2 mm and bridging in the bottom-discharge port. After binder spray, granules are dried to moisture 2.5%–4.0% and sieved to 16–40 mesh; fines below 80 mesh are re-granulated to prevent dose segregation in the sachet filler.

The finished oral granules are filled into aluminium-laminated sachets because the extract is hygroscopic in mono-layer polypropylene at 40°C and 75% relative humidity. A desiccant is not required when sachet water-vapour transmission rate is below 0.1 g/m²/day at 38°C and 90% relative humidity. Granule flow through auger fillers is stabilised with 0.5% colloidal silicon dioxide after drying; this also reduces caking during six-month storage at 40°C/75% RH. Dissolution or suspension tests are limited by the absence of a fully validated marker dissolution profile for this mixture; therefore the release test suite normally combines granule moisture, sieve analysis, marker content, and microbial limits rather than a single dissolution specification.

For soluble-powder presentations, the API is dry-blended with dextrose monohydrate or mannitol at a ratio of 1:10 to 1:50 and packaged in foil-lined polyethylene bags. The limiting process variable is rehydration behaviour in cold water at 10°C–15°C; spray-dried powder particles with an angle of repose above 45° wet slowly and leave floating aggregates on the surface of the mixing tank. Adding 1%–2% fumed silica and wetting agents such as 0.2% polysorbate 80 reduces surface tension and improves dispersion time to below 30 minutes with paddle agitation at 100 rpm. The final solution may be sieved through a 250 μm in-line filter before administration to remove undispersed botanical fibres that can block nipple drinkers in poultry and farrowing pens. The powder must meet total aerobic microbial count limits and absence of Salmonella in 25 g per ISO 6579-1:2017. Published data for dissolution and marker recovery in this specific soluble-powder configuration remain limited.